{{Rsnum
|rsid=11122834
|Gene=GLI2
|Chromosome=2
|position=120943713
|Orientation=plus
|GMAF=0.1152
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GLI2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 99.1 | 0.9 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 27.2 | 44.9 | 27.9
| ASW | 38.6 | 43.9 | 17.5
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 98.0 | 2.0 | 0.0
| LWK | 28.2 | 44.5 | 27.3
| MEX | 91.4 | 8.6 | 0.0
| MKK | 44.2 | 42.3 | 13.5
| TSI | 99.0 | 1.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20932654
|Trait=None
|Title=Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated With the Development of Erectile Dysfunction in African-American Men After Radiotherapy for Prostate Cancer
|RiskAllele=
|Pval=0.000005
|OR=4.93
|ORtxt=[NR]
|OA=1
}}

{{on chip | Affy GenomeWide 6}}